The detailed information for PTAB case with proceeding number PGR2017-00022 filed by Grunenthal GmbH et al. against Antecip Bioventures II LLC et al. on May 8, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
PGR2017-00022
Filing Date
May 8, 2017
Petitioner
Grunenthal GmbH et al.
Respondent
Antecip Bioventures II LLC et al.
Status
Final Written Decision
Respondent Application Number
14968514
Respondent Tech Center
1600
Respondent Patent Number
9408862
Institution Decision Date
Nov 15, 2017
Termination Date
Nov 14, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Patent Owner's Notice of Appeal Under 37 C.F.R. 90.2

Jan 16, 2019PAPERPATENT OWNER

Petitioner's Second Updated Mandatory Notices

Nov 15, 2018PAPERPETITIONER

Final Written Decision

Nov 14, 2018PAPERBOARD

Hearing Transcript

Aug 3, 2018PAPERBOARD

Petitioner's Opposition to Patent Owner's Motion to Exclude Evidence

Jul 3, 2018PAPERPETITIONER

ORDER Oral Hearing

Jun 25, 2018PAPERBOARD

Patent Owner's Motion to Exclude

Jun 21, 2018PAPERPATENT OWNER

Petitioner's Request for Oral Argument

Jun 19, 2018PAPERPETITIONER

Patent Owner's Request for Oral Argument

Jun 19, 2018PAPERPATENT OWNER

Patent Owner's Reply to Petitioner's Opposition to Patent Owner's Corrected Contingent Motion to Amend

Jun 1, 2018PAPERPATENT OWNER

Exhibit 2034

Jun 1, 2018EXHIBITPATENT OWNER

Exhibit 2035

Jun 1, 2018EXHIBITPATENT OWNER

Exhibit 2036

Jun 1, 2018EXHIBITPATENT OWNER

Exhibit 2037

Jun 1, 2018EXHIBITPATENT OWNER

Exhibit 2041

Jun 1, 2018EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Jun 1, 2018PAPERPATENT OWNER

Exhibit 2038

Jun 1, 2018EXHIBITPATENT OWNER

Exhibit 2039

Jun 1, 2018EXHIBITPATENT OWNER

Exhibit 2040

Jun 1, 2018EXHIBITPATENT OWNER

Patent Owner's Objections to Petitioner's Evidence Filed with Petitioner's Reply and Petitioner's Opposition to Patent Owner's Motion to Amend

May 8, 2018PAPERPATENT OWNER

Conduct of the Proceeding

May 7, 2018PAPERBOARD

Petitioner's Reply

May 3, 2018PAPERPETITIONER

Petitioner's Second Amended Exhibit List

May 3, 2018PAPERPETITIONER

Affidavit of Christopher Butler

May 3, 2018EXHIBITPETITIONER

FDA Guidance

May 3, 2018EXHIBITPETITIONER

Petitioner's Opposition to Patent Owner's Corrected Contingent Motion to Amend

May 3, 2018PAPERPETITIONER

Reply Declaration of Dr. Clive G. Wilson

May 3, 2018EXHIBITPETITIONER

Yamada

May 3, 2018EXHIBITPETITIONER

Lui

May 3, 2018EXHIBITPETITIONER

Hanna

May 3, 2018EXHIBITPETITIONER

Toutain

May 3, 2018EXHIBITPETITIONER

Deposition Transcript of Dr. William Wargin (Apr. 10, 2018)

May 3, 2018EXHIBITPETITIONER

Declaration of David Brayden, Ph.D.

May 3, 2018EXHIBITPETITIONER

Curriculum Vitae of David Brayden, Ph.D.

May 3, 2018EXHIBITPETITIONER

Leonard 2006

May 3, 2018EXHIBITPETITIONER

Baldrick

May 3, 2018EXHIBITPETITIONER

Maher 2009

May 3, 2018EXHIBITPETITIONER

Wang

May 3, 2018EXHIBITPETITIONER

Hardee

May 3, 2018EXHIBITPETITIONER

Maher 2016

May 3, 2018EXHIBITPETITIONER

Eaimtrakarn

May 3, 2018EXHIBITPETITIONER

Reply Declaration of Stephen Bruehl, Ph.D.

May 3, 2018EXHIBITPETITIONER

Aungst

May 3, 2018EXHIBITPETITIONER

Lee

May 3, 2018EXHIBITPETITIONER

Moroz

May 3, 2018EXHIBITPETITIONER

Patent Owner's Updated Exhibit List

Apr 10, 2018PAPERPATENT OWNER

Notice of Second Stipulation Regarding Schedule

Apr 6, 2018PAPERPETITIONER

Petitioner's Notice of Deposition of Dr. William Wargin

Mar 6, 2018PAPERPETITIONER

Patent Owner's Corrected Contingent Motion to Amend the Claims

Feb 27, 2018PAPERPATENT OWNER

Petitioner's Updated Mandatory Notices

Feb 21, 2018PAPERPETITIONER

Petitioner's Objections to Evidence

Feb 15, 2018PAPERPETITIONER

Order - re Patent Owner's Contingent Motion to Amend

Feb 13, 2018PAPERBOARD

Exhibit 2019

Feb 8, 2018EXHIBITPATENT OWNER

Exhibit 2020

Feb 8, 2018EXHIBITPATENT OWNER

Exhibit 2025

Feb 8, 2018EXHIBITPATENT OWNER

Exhibit 2026

Feb 8, 2018EXHIBITPATENT OWNER

Patent Owner's Contingent Motion to Amend

Feb 8, 2018PAPERPATENT OWNER

Exhibit 2027

Feb 8, 2018EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Feb 8, 2018PAPERPATENT OWNER

Patent Owner's Response

Feb 8, 2018PAPERPATENT OWNER

Exhibit 2021

Feb 8, 2018EXHIBITPATENT OWNER

Exhibit 2022

Feb 8, 2018EXHIBITPATENT OWNER

Exhibit 2023

Feb 8, 2018EXHIBITPATENT OWNER

Exhibit 2024

Feb 8, 2018EXHIBITPATENT OWNER

Order - Conduct of the Proceeding - 37 CFR 42.5

Jan 30, 2018PAPERBOARD

Notice of Stipulation Regarding Schedule

Dec 18, 2017PAPERPATENT OWNER

Decision Granting Motions for Pro Hac Vice Recognition of James R. Tyminski Jr. and Ms. Melinda R. Roberts

Dec 4, 2017PAPERBOARD

Patent Owner's Notice of Deposition of Clive G. Wilson

Dec 4, 2017PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Stephen Bruehl

Dec 4, 2017PAPERPATENT OWNER

Patent Owner's Objections to Petitioner's Evidence

Nov 29, 2017PAPERPATENT OWNER

Declaration in Support of Petitioner's Motion for Pro Hac Vice Admission of James R. Tyminski Jr.

Nov 29, 2017EXHIBITPETITIONER

Petitioner's Motion for Pro Hac Vice Admission of James R. Tyminski Jr. Under 37 C.F.R. 42.10

Nov 29, 2017PAPERPETITIONER

Petitioner's Motion for Pro Hac Vice Admission of Melinda R. Roberts Under 37 C.F.R. 42.10

Nov 29, 2017PAPERPETITIONER

Declaration in Support of Petitioner's Motion for Pro Hac Vice Admission of Melinda R. Roberts

Nov 29, 2017EXHIBITPETITIONER

Petitioner's First Amended Exhibit List

Nov 29, 2017PAPERPETITIONER

Trial Instituted Document

Nov 15, 2017PAPERBOARD

Scheduling Order

Nov 15, 2017PAPERBOARD

Granting Motion to Withdraw 37 C.F.R. sec 42.10

Oct 17, 2017PAPERBOARD

Patent Owner's Unopposed Motion for Withdrawal of Counsel

Sep 29, 2017PAPERPATENT OWNER

Patent Owner's Power of Attorney

Sep 29, 2017PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

Sep 29, 2017PAPERPATENT OWNER

Exhibit 2018

Sep 29, 2017EXHIBITPATENT OWNER

Order Conditionally Granting Patent Owner¿¿¿s Motions for Pro Hac Vice Admission of Michael Katz

Sep 25, 2017PAPERBOARD

Motion for Pro Hac Vice Admission

Aug 23, 2017PAPERPATENT OWNER

Declaration of Michael Katz in Support of Motion for Pro Hac Vice Admission

Aug 23, 2017PAPERPATENT OWNER

Patent Owner's Preliminary Response

Aug 23, 2017PAPERPATENT OWNER

Expert Declaration of Dr. Socrates Papapoulos

Aug 23, 2017EXHIBITPATENT OWNER

Expert Declaration of Dr. William Wargin

Aug 23, 2017EXHIBITPATENT OWNER

Curriculum vitae for Dr. Papapoulos

Aug 23, 2017EXHIBITPATENT OWNER

Curriculum vitae for Dr. Wargin

Aug 23, 2017EXHIBITPATENT OWNER

U.S. Patent App. Publication No. 2014/0051669

Aug 23, 2017EXHIBITPATENT OWNER

Brashier, Tiotropium administered by a pressurized metered dose inhaler (pDMI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler¿¿ in adult subjects with stable moderate-to-severe COPD

Aug 23, 2017EXHIBITPATENT OWNER

GUIDANCE FOR INDUSTRY: ESTIMATING THE MAXIMUM SAFE STARTING DOSE IN INITIAL CLINICAL TRIALS FOR THERAPEUTICS IN ADULT HEALTHY VOLUNTEERS, July 2005

Aug 23, 2017EXHIBITPATENT OWNER

Conte, Safety of intravenous and oral bisphosphonates and compliance with dosing regimens, THE ONCOLOGIST 2004

Aug 23, 2017EXHIBITPATENT OWNER

Ringe, Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis, PATIENT PREFERENCE AND ADHERENCE 2010

Aug 23, 2017EXHIBITPATENT OWNER

Thar Pharmaceuticals, INVESTOR PRESENTATION, Winter 2015

Aug 23, 2017EXHIBITPATENT OWNER

Black, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, THE LANCET 1996

Aug 23, 2017EXHIBITPATENT OWNER

Harris, Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women with Postmenopausal Osteoporosis, JAMA 1999

Aug 23, 2017EXHIBITPATENT OWNER

Chesnut, Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis, JOURNAL OF BONE AND MINERAL RESEARCH 2004

Aug 23, 2017EXHIBITPATENT OWNER

Goldman-Levine, Zoledronic Acid (Reclast) for Osteoporosis, AM FAM PHYSICIAN 2008

Aug 23, 2017EXHIBITPATENT OWNER

Green, Preclinical Pharmocaology of CGP 42¿¿¿446, a New, Potent, Heterocyclic Bisphosphonate Compound, JOURNAL OF BONE AND MINERAL RESEARCH 1994

Aug 23, 2017EXHIBITPATENT OWNER

U.S. Patent App. Publication No. 2010/0215743

Aug 23, 2017EXHIBITPATENT OWNER

Isinga, Administration Costs of Denosumab and Zoledronic Acid for Postmenopausal Osteoporosis, AM J PHARM BENEFITS 2016

Aug 23, 2017EXHIBITPATENT OWNER

Patent Owner's Power of Attorney

Jul 21, 2017PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notice

Jul 21, 2017PAPERPATENT OWNER

Patent Owner's Mandatory Notices

May 30, 2017PAPERPATENT OWNER

Power of Attorney for Patent Owner

May 30, 2017PAPERPATENT OWNER

Notice of Accord Filing Date

May 23, 2017PAPERBOARD

Power of Attorney

May 8, 2017PAPERPETITIONER

Fox

May 8, 2017EXHIBITPETITIONER

Laslett

May 8, 2017EXHIBITPETITIONER

Leonard

May 8, 2017EXHIBITPETITIONER

Zometa Drug Label

May 8, 2017EXHIBITPETITIONER

Walker

May 8, 2017EXHIBITPETITIONER

Devogelaer

May 8, 2017EXHIBITPETITIONER

Schott

May 8, 2017EXHIBITPETITIONER

Classification of Chronic Pain

May 8, 2017EXHIBITPETITIONER

Ruza

May 8, 2017EXHIBITPETITIONER

U.S. Patent No. 9,408,862

May 8, 2017EXHIBITPETITIONER

Fosamax Drug Label

May 8, 2017EXHIBITPETITIONER

Wardley

May 8, 2017EXHIBITPETITIONER

Adami

May 8, 2017EXHIBITPETITIONER

Maillefert

May 8, 2017EXHIBITPETITIONER

Siminoski

May 8, 2017EXHIBITPETITIONER

Cortet

May 8, 2017EXHIBITPETITIONER

Robinson

May 8, 2017EXHIBITPETITIONER

Kubalek

May 8, 2017EXHIBITPETITIONER

Woolf

May 8, 2017EXHIBITPETITIONER

Int'l Patent App. Pub. No. WO2011/014781

May 8, 2017EXHIBITPETITIONER

Pazianas

May 8, 2017EXHIBITPETITIONER

Sorbera

May 8, 2017EXHIBITPETITIONER

Carbonare

May 8, 2017EXHIBITPETITIONER

McHugh

May 8, 2017EXHIBITPETITIONER

WHO good manufacturing practices

May 8, 2017EXHIBITPETITIONER

Int'l Patent App. Pub. No. WO2005/005447

May 8, 2017EXHIBITPETITIONER

Aungst

May 8, 2017EXHIBITPETITIONER

Excerpt of File History for U.S. Patent No. 7,704,977

May 8, 2017EXHIBITPETITIONER

Merrion Poster

May 8, 2017EXHIBITPETITIONER

U.S. Patent No. 9,216,168

May 8, 2017EXHIBITPETITIONER

Testim Drug Label

May 8, 2017EXHIBITPETITIONER

Losina

May 8, 2017EXHIBITPETITIONER

Harden

May 8, 2017EXHIBITPETITIONER

Spector

May 8, 2017EXHIBITPETITIONER

Spector 1048

May 8, 2017EXHIBITPETITIONER

Carbone

May 8, 2017EXHIBITPETITIONER

Fujita

May 8, 2017EXHIBITPETITIONER

Piscitelli

May 8, 2017EXHIBITPETITIONER

Chen

May 8, 2017EXHIBITPETITIONER

Harden 1055

May 8, 2017EXHIBITPETITIONER

Chapter 3: Pharmacokinetics

May 8, 2017EXHIBITPETITIONER

Riedel

May 8, 2017EXHIBITPETITIONER

Harden 1056

May 8, 2017EXHIBITPETITIONER

Bruehl

May 8, 2017EXHIBITPETITIONER

Handbook of Pharm. Excipients

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 2

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 5

May 8, 2017EXHIBITPETITIONER

McHugh 1064

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent No. 9,216,168

May 8, 2017EXHIBITPETITIONER

Leonard 1065

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 1

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 3

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 4

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 6

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent App. No. 13/394,244 7

May 8, 2017EXHIBITPETITIONER

CV of Stephen Bruehl Ph.D.

May 8, 2017EXHIBITPETITIONER

Declaration of Clive G. Wilson Ph.D.

May 8, 2017EXHIBITPETITIONER

File History U.S. Patent 9,408,862

May 8, 2017EXHIBITPETITIONER

Declaration of Stephen Bruehl, Ph.D.

May 8, 2017EXHIBITPETITIONER

CV of Clive G. Wilson Ph.D.

May 8, 2017EXHIBITPETITIONER

Petition for Post Grant Review of U.S. Patent No. 9,408,862

May 8, 2017PAPERPETITIONER

File History of U.S. Patent App. No. 15/378939

May 8, 2017EXHIBITPETITIONER